Upon receipt at medtronic¿s quality laboratory, visual examination revealed the valve was slightly distorted.Pledgets were seen embedded in pannus around the sewing ring.All leaflets were in the closed position.The right cusp was prolapsed due to a leaflet tear/abrasion adjacent to the left right stent post.All leaflets were slightly stiff but flexible except where pannus extended onto the tissue (outflow).Tears/abrasions were noted in the belly of the right and the left cusps which is consistent with historical findings of cusp contact with the bias cloth.Damage size may have increased during explant.All stent posts were encapsulated with pannus and all outflow rails extending to the base stitching and 1 to 3 mm onto all cusps reducing the inflow orifice area.Pannus extended to all superior coaptive areas and some areas of the sewing ring.An unknown amount of pannus appeared to have been removed on the inflow and outflow during explant.Pannus overgrowth was observed on the valve which extended from the left non-coronary stent post to the left cusp, which may have contributed to the tear of the left cusp (during valve opening, the left cusp contacted the bias cloth and may have also contacted the pannus).Deflection of the stent posts and/or distortion of the valve can result in more contact of the leaflet onto the cloth due to the altered position of the outflow rail and stent posts.The tear and abrasions seen in the right / left cusps may have been a result of the altered position of the stent post since the position of the deflection resulted in the narrowing of this outflow rail opening.Exactly when and how the stent post deflection or valve distortion occurred cannot be determined; however, per medtronic¿s inspection procedure each valve is inspected for distortion/deflection and this valve was confirmed to have passed the inspection prior to release for distribution.Radiography revealed calcification embedded in pannus on the left right stent post and along the sewing ring.No calcification was found on the leaflets.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Reduced performance of the valve is attributed to host tissue overgrowth.This finding is generally considered a patient-related condition.Pannus overgrowth is an inherent risk of surgical valve replacement.If information is provided in the future, a supplemental report will be issued.
|